BioView Ltd. (IL:BIOV)
TASE:BIOV
Total Valuation
Bio View has a market cap or net worth of ₪22.65M. The enterprise value is 16.87M.
Market Cap₪22.65M
Enterprise Value16.87M
Share Statistics
Bio View has 138,986,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding138,986,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bio View’s return on equity (ROE) is -1.63 and return on invested capital (ROIC) is -62.01%.
Return on Equity (ROE)-1.63
Return on Assets (ROA)-0.77
Return on Invested Capital (ROIC)-62.01%
Return on Capital Employed (ROCE)-0.69
Revenue Per Employee603.94K
Profits Per Employee-464.61K
Employee Count33
Asset Turnover1.00
Inventory Turnover1.84
Valuation Ratios
The current PE Ratio of Bio View is ―. Bio View’s PEG ratio is -0.00369.
PE Ratio―
PS Ratio1.14
PB Ratio2.41
Price to Fair Value2.41
Price to FCF-7.28
Price to Operating Cash Flow-4.43
PEG Ratio-0.00369
Income Statement
In the last 12 months, Bio View had revenue of 19.93M and earned -15.33M in profits. Earnings per share was -0.11.
Revenue19.93M
Gross Profit8.75M
Operating Income-7.80M
Pretax Income-9.15M
Net Income-15.33M
EBITDA-5.96M
Earnings Per Share (EPS)-0.11
Cash Flow
In the last 12 months, operating cash flow was -5.66M and capital expenditures -81.00K, giving a free cash flow of -5.74M billion.
Operating Cash Flow-5.66M
Free Cash Flow-5.74M
Free Cash Flow per Share-0.04
Dividends & Yields
Bio View pays an annual dividend of 200, resulting in a dividend yield of ―
Dividend Per Share200
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.11
52-Week Price Change-48.44%
50-Day Moving Average16.60
200-Day Moving Average18.50
Relative Strength Index (RSI)43.66
Average Volume (3m)133.91K
Important Dates
Bio View upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Bio View as a current ratio of 1.88, with Debt / Equity ratio of 9.33%
Current Ratio1.88
Quick Ratio1.17
Debt to Market Cap0.06
Net Debt to EBITDA0.36
Interest Coverage Ratio-33.63
Taxes
In the past 12 months, Bio View has paid 6.18M in taxes.
Income Tax6.18M
Effective Tax Rate-0.68
Enterprise Valuation
Bio View EV to EBITDA ratio is -3.44, with an EV/FCF ratio of -6.60.
EV to Sales1.03
EV to EBITDA-3.44
EV to Free Cash Flow-6.60
EV to Operating Cash Flow-6.71
Balance Sheet
Bio View has ₪7.84M in cash and marketable securities with ₪1.86M in debt, giving a net cash position of ₪5.98M billion.
Cash & Marketable Securities₪7.84M
Total Debt₪1.86M
Net Cash₪5.98M
Net Cash Per Share₪0.04
Tangible Book Value Per Share₪0.07
Margins
Gross margin is 46.02%, with operating margin of -39.15%, and net profit margin of -76.93%.
Gross Margin46.02%
Operating Margin-39.15%
Pretax Margin-45.90%
Net Profit Margin-76.93%
EBITDA Margin-29.91%
EBIT Margin-39.15%
Analyst Forecast
The average price target for Bio View is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―